{
    "address": "Karolinska Institutet Science Park, Halsovagen 7",
    "city": "Huddinge",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W6S1KX105",
    "description": "NextCell Pharma AB engages in the development of stem cell products. The company is headquartered in Huddinge, Stockholm. The company went IPO on 2017-07-13. The firm is located in Huddinge, Sweden.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2017-07-13",
    "isin": "SE0009723125",
    "logo": "",
    "marketCapitalization": 495.0651,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in Biotechnology",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "NextCell Pharma AB",
    "phone": "4687355595.0",
    "sedol": "BF02MH1",
    "shareOutstanding": 33.712853,
    "state": "STOCKHOLM",
    "ticker": "NXTCL.ST",
    "weburl": "http://www.nextcellpharma.com/"
}